Clinical Follow-Up of 11 Argentinian CD40L-Deficient Patients with 7 Unique Mutations Including the So-Called “Milder” Mutants
- 148 Downloads
CD40 ligand (CD40L) deficiency is an X-linked combined immunodeficiency characterized by impaired class switch recombination. We analyzed clinical and molecular findings in 11 Argentinian patients from seven unrelated families. The mean age at onset of symptoms was 1.1 years (0.5–3.0 years) and the 10 alive patients have a median age of 17 years. We identified two nonsense mutations, including R11X reported as a “hypomorphic” defect, four missense mutations, and one point deletion. Although R11X was associated herein with parvovirus B19-anemia and higher Igs levels as previously described, histoplasmosis and Pneumocystis jiroveci pneumonia were also present. Other so-called “milder” mutation, T254M, was present in three related patients clinically and immunologically undistinguishable from the rest of the cohort. Furthermore, 10 of the 11 patients, having heterogeneous mutations, never had persistent neutropenia, none presented Cryptosporidium sp. infection nor developed liver-biliary tract disease, highlighting the debatable concept of “milder” mutations.
KEY WORDS:CD40 ligand X-linked hyper IgM immunodeficiency Mutation analysis
The technical expertise of Emma Prieto is gratefully acknowledged.
- 3.Aruffo A, Farrington M, Hollenbaugh D, Li X, Milatovich A, Nonoyama S, Bajorath J, Grosmaire LS, Stenkamp R, Neubauer M, Roberts RL, Noelle RJ, Ledbetter JA, Francke U, Ochs HD: The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM Syndrome. Cell 72:291–300, 1993PubMedCrossRefGoogle Scholar
- 5.Ferrari S, Giliani S, Insalaco A, Al-Ghonaium A, Soresina AR, Loubser M, Avanzini MA, Marconi M, Badolato R, Ugazio AG, Levy Y, Catalan N, Durandy A, Tbakhi A, Notarangelo LD, Plebani A: Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc Natl Acad Sci USA 98:12614–12619, 2001PubMedCrossRefGoogle Scholar
- 8.Villa A, Notarangelo LD, Di Santo JP, Macchi PP, Strina D, Frattini A, Lucchini F, Patrosso CM, Giliani S, Mantuano E, Agosti S, Nocera G, Kroczek RA, Fischer A, Ugazio AG, de Saint Basile G, Vezzoni P: Organization of the human CD40L gene: Implications for molecular defects in X chromosome-linked hyper-IgM syndrome and prenatal diagnosis. Proc Natl Acad Sci USA 91:2110–2114, 1994PubMedCrossRefGoogle Scholar
- 15.Ziegner UHM, Kobayashi RH, Cunningham-Rundles C, Español T, Fasth A, Huttenlocker A, Krogstad P, Marthinsen L, Notarangelo LD, Pasic S, Rieger CHL, Rudge P, Sankar R, Shigeoka AO, Stiehm ER, Sullivan KE, Webster AD, Ochs HD: Progressive neurodegeneration in patients with primary immunodeficiency disease on IVIG treatment. Clin Immunol 102:19–24, 2002PubMedCrossRefGoogle Scholar
- 16.Levy J, Español-Boren T, Thomas C, Fischer A, Tobo P, Bordigoni P, Resnick I, Fasth A, Baer M, Gómez L, Sandera EA, Tabone M-D, Plantaz D, Etzioni A, Monafo V, Abinum M, Hammarstrom L, Abrahamsen T, Jones A, Finn A, Klemola T, DeVries E, Sanal O, Peitsch MC, Notarangelo LD: Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr 131:47–54, 1997PubMedCrossRefGoogle Scholar